12.700
−14,77%
2026-10-16
Fundamental Analysis
96 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +75.8% | +63.9% | 3 / 3 | +66.2% | +13.46 pp | +78.55 pp | +31.0% | -3.75 | — | 46,0 | +66,2% | −6,1 | +75,8% | — | -1.56 | — |
| Pts | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 12.700 (close price on 2026-10-16)EPS (TTM): −5.964,5
Financial charts
1.Revenue & growth
VND bn46,0Q2/26
1.Revenue & growth
VND bn46,0Q2/26
2.Profit & growth
VND bn-6,15Q2/26
3.Profit mix (Penman)
VND bn-51,4Q2/26
4.Margins & cost structure
%33.6%Q2/26
5.Returns & cash cycle
% · days-0.5%Q2/26
6.Earnings quality & cash
VND bn22,7Q2/26
7.Asset structure
VND bn595Q2/26
8.Funding & debt health
VND bn · times595Q2/26
9.Revenue backlog
VND bn0,16Q2/26
10.Valuation
times · %-2,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-723Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26